FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway

Genes and Development

Volumn 13, Issue 11, 1999, Pages 1361-1366

  Sahni, Malika ^a   Ambrosetti, Davide Carlo ^a   Mansukhani, Alka ^a   Gertner, Rachel ^a   Levy, David ^a   Basilico, Claudio ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone development; Chondrocytic maturation; FGF signaling; STAT 1

Indexed keywords

FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR; STAT1 PROTEIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; DOWN REGULATION; DWARFISM; GROWTH INHIBITION; KNOCKOUT MOUSE; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALIA; MURINAE;

EID: 0033151612     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.11.1361     Document Type: Article

References (28)

1. Abdollahi, A., K.A. Lord, B. Hoffman-Liebermann, and D.A. Liebermann. 1991. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: Role in growth inhibition. Cell Growth Differ. 2: 401-407.
2. Amling, M., L. Neff, S. Tanaka, D. Inoue, K. Kuida, E. Weir, W.M. Philbrick, A.E Broadus, and R. Baron. 1997. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J. Cell Biol. 136: 205-213.
3. Basilico, C. and D. Moscatelli. 1992. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59: 115-165.
4. Burke, D., D. Wilkes, T.L. Blundell, and S. Malcolm. 1998. Fibroblast growth factor receptors: Lessons from the genes. Trends Biochem. Sci. 23: 259-262.
5. CIP1 mediated by STAT1. Science 272: 719-722.
6. Coffin, J.D., R.Z. Florkiewicz, J. Neumann, T. Mort-Hopkins, G.W. Dorn, P. Lightfoot, R. German, P.N. Howles, A. Kier, B.A. O'Toole, J. Sasse, A.M. Gonzalez, A. Baird, and T. Doetschman. 1995. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell 6: 1861-1873.
7. Colvin, J.S., B.A. Bohne, G.W. Harding, D.G. McEwen, and D.M. Omitz. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12: 390-397.
8. Darnell, J.E., Jr. 1997. STATs and gene regulation. Science 277: 1630-1635.
9. Deng, C., A. Wynshaw-Boris, F. Zhou, A. Kuo, and P. Leder. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84: 911-921.
10. Durbin, J.E., R. Hackenmiller, M.C. Simon, and D.E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450.
11. Goldfarb, M. 1996. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev. 7: 311-325.
12. Hill, D.J., A. Logan, and D. De Sousa. 1991. Stimulation of DNA and protein synthesis in epiphyseal growth plate chondrocytes by fibroblast growth factors. Interactions with other peptide growth factors. Ann. N.Y. Acad. Sci. 638: 449-452.
13. Kato, Y. and M. Iwamoto.. 1990. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J. Biol. Chem. 265: 5903-5909.
14. Legeai-Mallet, L., C. Benoist-Lasselin, A.-L. Delezoide, A. Munnich, and J. Bonaventure. 1998. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J. Biol. Chem. 273: 13007-13014.
15. Li, C., L. Chen, T. Iwata, M. Kitagawa, X.-Y. Fu, and C.-X. Deng. 1999. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum. Mol. Genet. 8: 35-44.
16. Li, Y., K. Mangasarian, A. Mansukhani, and C. Basilico. 1997. Activation of FGF receptors by mutations in the transmembrane domain. Oncogens 14: 1397-1406.
17. Mancilla, E.E., F. De Luca, J.A. Uyeda, F.S. Czerwiec, and J. Baron. 1998. Effects of fibroblast growth factor-2 on longitudinal bone growth. Endocrinology 139: 2900-2904.
18. Mukhopadhyay, K., V. Lefebvre, G. Zhou, S. Garofalo, J.H. Kimura, and B. de Crombrugghe. 1995. Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse Pro-α1(II) collagen gene. J. Biol. Chem. 270: 27711-27719.
19. Naski, M.C. and D.M. Ornitz. 1998. FGF signaling in skeletal development. Front. Biosci. 3: 781-794.
20. Naski, M.C., J.S. Colvin, J.D. Coffin, and D.M. Ornitz. 1998. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125: 4977-4988.
21. Ornitz, D.M., J. Xu, J.S. Colvin, D.G. McEwen, C.A. MacArthur, F. Coulier, G. Gao, and M. Goldfarb. 1996. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271: 15292-15297.
22. Saxton, T.M., M. Henkemeyer, S. Gasca, R. Shem, D.J. Rossi, F. Shalaby, G.-S. Feng, and T. Pawson. 1997. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16: 2352-2364.
23. Shah, K., R. Astley, and A.H. Cameron. 1973. Thanatophoric dwarfism. J. Med. Genet. 10: 243-252.
24. Silvennoinen, O., C. Schindler, J. Schlessinger, and D.E. Levy. 1993. Ras-independent signal transduction in response to growth factors and cytokines by tyrosine phosphorylation of a common transcription factor. Science 261: 1736-1739.
25. Stanescu, R., V. Stanescu, and P. Maroteaux. 1990. Homozygous achondroplasia: Morphologic and biochemical study of cartilage. Am. J. Med. Genet. 37: 414-421.
26. Su, W.-C., M. Kitagawa, N. Xue, B. Xie, S. Garofalo, J. Cho, C. Deng, W.A. Horton, and X.-Y. Fu. 1997. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386: 288-292.
27. Webster, M.K. and D.J. Donoghue. 1997. FGFR activation in skeletal disorders: Too much of a good thing. Trends Genet. 13: 178-182.
28. Wroblewski, J. and C. Edwall-Arvidsson. 1995. Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J. Bone Miner. Res. 10: 735-742.